Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan

NCT00212667 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

650

Enrollment

INDUSTRY

Sponsor class

Conditions

Involutional Osteoporosis

Interventions

DRUG: ONO-5920

Sponsor

Ono Pharmaceutical Co., Ltd.

Collaborators

[object Object]